Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7S3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,141
Award facts
- Contract value 100% obligated
- $12,140.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,140.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 14, 2026, for the supply of Dupixent 300 mg/2 mL pens with an ultimate completion date of January 15, 2026. This non-set-aside award was competitively procured and performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 31, 2031, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Dupixent is a specialty biologic medication indicated for treating conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. This delivery order represents one of numerous pharmaceutical procurements executed under Cencora's prime IDC with DLA, reflecting the agency's continued reliance on established vendor relationships for essential prescription medications and medical commodities. AmerisourceBergen's designation as a critical federal vendor across multiple therapeutic domains demonstrates its capability to efficiently fulfill government healthcare supply requirements for military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FV7S3?
SPE2DR26FV7S3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FV7S3 worth?
The government has obligated $12,141 on SPE2DR26FV7S3.
Is contract SPE2DR26FV7S3 an order under another contract?
Yes. SPE2DR26FV7S3 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7S3 competed?
The extent of competition for SPE2DR26FV7S3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award